Comparison of Two Hot Stocks: AbbVie Inc. (NYSE:ABBV) ; AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX)

AbbVie Inc. (NYSE:ABBV)

AbbVie Inc. (NYSE:ABBV) closed at $88.2 on the last trading session with an increase of 0.44%, whereas, it previously closed at $87.81. The company has a market capitalization of $132.91 Billion. The company traded shares of 6.52 Million on the trading day while its three month average volume stands at 7.16 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of AbbVie Inc. (NYSE:ABBV) produced diluted EPS of 5.08. The EPS estimate for next year as estimated by analysts is at 8.72 while EPS for next quarter is estimated at 1.93. Earnings per Share growth for this year is reported at -2.4, while the analysts estimated the EPS growth for next year at 8.72% and Earnings growth for next 5 years stands at 16.97% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 1.2%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of AbbVie Inc. (NYSE:ABBV) is at 17.37 while the forward p/e is at 10.12. The P/S or Price to Sales ratio of AbbVie Inc. (NYSE:ABBV) stands at 4.13 and Price to Book or P/B for the most recent quarter stands at 0. The Price to Free Cash Flow ratio or P/FCF is reported at 19.65. The quick ratio and the current ratio of AbbVie Inc. (NYSE:ABBV) are reported at 1.1 and 1.2 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for AbbVie Inc. (NYSE:ABBV) stands at 11.2, 0 and 17.8 respectively

The trailing twelve month Revenue of AbbVie Inc. (NYSE:ABBV) is reported at 32.19 Billion with income of 7.93 Billion. The outstanding shares of AbbVie Inc. (NYSE:ABBV) are 1.51 Billion. The institutional Ownership of the shares of 72.3 stands at 0.80%, this figure is increased 0.17 in the last six months. The insider ownership for the shares of AbbVie Inc. (NYSE:ABBV) is ticked at 0.07%, the figure is plummeted -20.77% in the last six months.

Some other important financial aspects to be discussed here for AbbVie Inc. (NYSE:ABBV) is the Mean Target Price estimated by the analysts which stands at 99.39. The 52 week high of AbbVie Inc. (NYSE:ABBV) is placed at 125.86 and 52 week low is standing at 77.50.

Performance wise the shares of AbbVie Inc. (NYSE:ABBV) rose up 2.21% for the week, it also rise 0.67% for the monthly performance, while for the quarter it went up -6.74%. The shares decrease -7.12% for the half year and plummeted for the Year-To-Date performance. The shares of AbbVie Inc. (NYSE:ABBV) shrinked -12.01% for the yearly performance.

AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX)

AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) closed at $2.71 on the last trading session with an decrease of -1.45%, whereas, it previously closed at $2.75. The company has a market capitalization of $182.68 Million. The company traded shares of 1.28 Million on the trading day while its three month average volume stands at 4.11 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) produced diluted EPS of -0.16. The EPS estimate for next year as estimated by analysts is at -0.96 while EPS for next quarter is estimated at -0.2. Earnings per Share growth for this year is reported at 61, while the analysts estimated the EPS growth for next year at -0.96% and Earnings growth for next 5 years stands at 0% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 24.4%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) is at 0 while the forward p/e is at 0. The P/S or Price to Sales ratio of AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) stands at 79.43 and Price to Book or P/B for the most recent quarter stands at 0. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) are reported at 4.5 and 4.6 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) stands at -62.7, 104.6 and -5.9 respectively

The trailing twelve month Revenue of AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) is reported at 2.3 Million with income of -10400000. The outstanding shares of AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) are 67.41 Million. The institutional Ownership of the shares of 10.4 stands at 0.80%, this figure is increased 0.4 in the last six months. The insider ownership for the shares of AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) is ticked at 1.1%, the figure is rose 11.6% in the last six months.

Some other important financial aspects to be discussed here for AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) is the Mean Target Price estimated by the analysts which stands at 8.67. The 52 week high of AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) is placed at 5.05 and 52 week low is standing at 1.65.

Performance wise the shares of AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) rose up 4.23% for the week, it also fell -18.86% for the monthly performance, while for the quarter it went up -9.36%. The shares decrease -21.45% for the half year and flew up for the Year-To-Date performance. The shares of AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) grew 27.53% for the yearly performance.